| Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
| 2016 | 151P: Outcomes of research biopsies in clinical trials of EGFR mutation-positive NSCLC patients pretreated with EGFR-TKIs | BIN-CHI LIAO ; Bai Y.-Y.; CHIA-CHI LIN ; SHU-YUNG LIN ; YEE-FAN LEE ; CHAO-CHI HO ; JIN-YUAN SHIH ; YEUN-CHUNG CHANG ; CHONG-JEN YU ; CHIH-HSIN YANG | Journal of Thoracic Oncology | 1 | 1 | |
| 2016 | 205P: Visualizing ZO-1-mediated coupled migration between cancer and stromal cells in lung cancer metastasis via a 5-dimensional cell imaging system | Lu H.-H.; Chen B.-C.; HUEI-WEN CHEN ; CHAO-CHI HO ; CHONG-JEN YU | Journal of Thoracic Oncology | 0 | 0 | |
| 2002 | 8 Role of immunohistochemical expression of caveolin-1 in lung carcinoma | CHAO-CHI HO ; PEI-HSIN HUANG ; PAN-CHYR YANG ; Hsu S.-M. | Handbook of Immunohistochemistry and in Situ Hybridization of Human Carcinomas | 1 | 0 | |
| 2017 | Acquired BRAF V600E Mutation as Resistant Mechanism after Treatment with Osimertinib | CHAO-CHI HO ; WEI-YU LIAO ; Lin C.-A.; JIN-YUAN SHIH ; CHONG-JEN YU ; Chih-Hsin CHIH-HSIN YANG | Journal of Thoracic Oncology | 171 | 161 | |
| 2016 | Acquisition of tumorigenic potential and enhancement of angiogenesis in pulmonary stem/progenitor cells through Oct-4 hyperexpression | Gu, Sing-Yi; CHAO-CHI HO ; Huang, Yung-Kang; HUEI-WEN CHEN ; Wang, Yu-Chi; Kuo, Chia-Yu; SHU-CHUN TENG ; WEN-MEI FU ; PAN-CHYR YANG ; Wu, Cheng-Wen; FU-CHUO PENG ; THAI-YEN LING | Oncotarget | 3 | 2 | |
| 2011 | Admissions to intensive care unit of HIV-infected patients in the era of highly active antiretroviral therapy: Etiology and prognostic factors | Chiang H.-H.; CHIEN-CHING HUNG ; Lee C.-M.; Chen H.-Y.; Chen M.-Y.; WANG-HUEI SHENG ; SZU-MIN HSIEH ; HSIN-YUN SUN ; CHAO-CHI HO ; CHONG-JEN YU | Critical Care | 55 | 55 | |
| 2008 | Adrenal insufficiency in prolonged critical illness | Wu J.-Y.; SZU-CHUN HSU ; SHIH-CHI KU ; CHAO-CHI HO ; CHONG-JEN YU ; PAN-CHYR YANG | Critical Care | 20 | 16 | |
| 2012 | Advanced non-small cell lung cancer in patients aged 45 years or younger: Outcomes and prognostic factors | CHIA-LIN HSU ; KUAN-YU CHEN ; JIN-YUAN SHIH ; CHAO-CHI HO ; CHIH-HSIN YANG ; CHONG-JEN YU ; PAN-CHYR YANG | BMC Cancer | 72 | 66 | |
| 2014 | Afatinib combined with cetuximab for lung adenocarcinoma with leptomeningeal carcinomatosis | Lin C.-H.; Lin M.-T.; YAO-WEN KUO ; CHAO-CHI HO | Lung Cancer | 25 | 21 | |
| 2021 | Afatinib Exerts Immunomodulatory Effects by Targeting the Pyrimidine Biosynthesis Enzyme CAD | Tu, Hsin-Fang; Chun-Jung Ko ; Lee, Ching-Tai; Lee, Cheng-Fan; Lan, Shao-Wei; Lin, Hsin-Hsien; Lin, Hsin-Ying; CHIA-CHI KU ; Lee, Der-Yen; I-CHUN CHEN ; YA-HUI CHUANG ; Del Caño-Ochoa, Francisco; Ramón-Maiques, Santiago; CHAO-CHI HO ; MING-SHYUE LEE ; GEEN-DONG CHANG | Cancer research | 14 | 12 | |
| 2020 | Antimetabolite pemetrexed primes a favorable tumor microenvironment for immune checkpoint blockade therapy | Lu C.-S.; Lin C.-W. ; Chang Y.-H.; Chen H.-Y.; Chung W.-C.; Lai W.-Y.; CHAO-CHI HO ; Wang T.-H.; Chen C.-Y.; Yeh C.-L.; Wu S.; Wang S.-P.; PAN-CHYR YANG | Journal for ImmunoTherapy of Cancer | 21 | 20 | |
| 2020 | Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors | CHING-YAO YANG ; WEI-YU LIAO ; CHAO-CHI HO ; KUAN-YU CHEN ; TZU-HSIU TSAI ; CHIA-LIN HSU ; KANG-YI SU ; YIH-LEONG CHANG ; CHEN-TU WU ; Chia-Chi Hsu; BIN-CHI LIAO ; Wei-Hsun Hsu; JIH-HSIANG LEE ; CHIA-CHI LIN ; JIN-YUAN SHIH ; CHIH-HSIN YANG ; CHONG-JEN YU | European Journal of Cancer | 52 | 46 | |
| 2020 | Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib | CHING-YAO YANG ; WEI-YU LIAO ; CHAO-CHI HO ; KUAN-YU CHEN ; TZU-HSIU TSAI ; CHIA-LIN HSU ; Liu, Yi-Nan; KANG-YI SU ; YIH-LEONG CHANG ; CHEN-TU WU ; BIN-CHI LIAO ; Hsu, Chia-Chi; Hsu, Wei-Hsun; JIH-HSIANG LEE ; CHIA-CHI LIN ; JIN-YUAN SHIH ; CHIH-HSIN YANG ; CHONG-JEN YU | Oncologist | 15 | 15 | |
| 2017 | Astrocyte-elevated gene-1 confers resistance to pemetrexed in non-small cell lung cancer by upregulating thymidylate synthase expression | CHUNG-YU CHEN ; Chen Y.-Y.; Chen J.J.W.; KUAN-YU CHEN ; CHAO-CHI HO ; JIN-YUAN SHIH ; YIH-LEONG CHANG ; CHONG-JEN YU ; PAN-CHYR YANG | Oncotarget | 9 | 9 | |
| 2019 | Atypical cells in pathology of endobronchial ultrasound-guided transbronchial biopsy of peripheral pulmonary lesions: incidence and clinical significance | CHUN-TA HUANG ; Tsai Y.-J.; CHAO-CHI HO ; CHONG-JEN YU | Surgical Endoscopy | 7 | 6 | |
| 2014 | Bcl-2-like protein 11 deletion polymorphism predicts survival in advanced non-small-cell lung cancer | JIH-HSIANG LEE ; Lin Y.-L.; Hsu W.-H.; Chen H.-Y.; YEUN-CHUNG CHANG ; CHONG-JEN YU ; JIN-YUAN SHIH ; CHIA-CHI LIN ; KUAN-YU CHEN ; CHAO-CHI HO ; WEI-YU LIAO ; PAN-CHYR YANG ; CHIH-HSIN YANG | Journal of Thoracic Oncology | 44 | 35 | |
| 2018 | Best Response According to RECIST During First-line EGFR-TKI Treatment Predicts Survival in EGFR Mutation-positive Non–Small-cell Lung Cancer Patients | Wu T.-H.; Hsiue E.H.-C.; JIH-HSIANG LEE ; CHIA-CHI LIN ; WEI-YU LIAO ; CHAO-CHI HO ; JIN-YUAN SHIH ; CHONG-JEN YU ; CHIH-HSIN YANG | Clinical Lung Cancer | 16 | 17 | |
| 2006 | C2GnT-M is downregulated in colorectal cancer and its re-expression causes growth inhibition of colon cancer cells | MIN-CHUAN HUANG ; Chen H.-Y.; Huang H.-C.; JOHN HUANG ; JIN-TUNG LIANG ; Shen T.-L.; NENG-YU LIN ; CHAO-CHI HO ; Cho I.-M.; Hsu S.-M. | Oncogene | 68 | 63 | |
| 2014 | Cancer-associated fibroblasts regulate the plasticity of lung cancer stemness via paracrine signalling | Chen W.-J.; CHAO-CHI HO ; YIH-LEONG CHANG ; Chen H.-Y.; Lin C.-A.; THAI-YEN LING ; SUNG-LIANG YU ; Yuan S.-S.; Louisa Chen Y.-J.; Lin C.-Y.; SZU-HUA PAN ; HAN-YI E. CHOU ; Chang G.-C.; Chu W.-C.; Lee Y.-M.; Lee J.-Y.; Lee P.-J.; Li K.-C.; HUEI-WEN CHEN ; PAN-CHYR YANG | Nature Communications | 302 | 278 | |
| 2008 | Caveolin-1 expression is significantly associated with drug resistance and poor prognosis in advanced non-small cell lung cancer patients treated with gemcitabine-based chemotherapy | CHAO-CHI HO ; SUNG-HSIN KUO ; PEI-HSIN HUANG ; Huang H.-Y.; CHIH-HSIN YANG ; PAN-CHYR YANG | Lung Cancer | 108 | 98 | |
